THE CHARACTERIZATION OF THE DOPAMINERGIC PROFILE OF EMD 23,448, AN INDOLYL-3-BUTYLAMINE - SELECTIVE ACTIONS ON PRESYNAPTIC AND SUPERSENSITIVE POSTSYNAPTIC DA RECEPTOR POPULATIONS

被引:7
作者
GOLDSTEIN, M
FUXE, K
MELLER, E
SEYFRIED, CA
AGNATI, L
MASCAGNI, FM
机构
[1] KAROLINSKA INST,DEPT HISTOL,POB 60400,S-10401 STOCKHOLM 60,SWEDEN
[2] UNIV MODENA,DEPT HUMAN PHYSIOL,I-41100 MODENA,ITALY
[3] NYU MED CTR,DEPT PSYCHIAT,NEW YORK,NY 10016
[4] E MERCK AG,DEPT NEUROCHEM,D-6100 DARMSTADT,FED REP GER
关键词
D O I
10.1007/BF01253598
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:193 / 215
页数:23
相关论文
共 43 条
[1]  
Agnati L F, 1984, Acta Physiol Scand Suppl, V532, P5
[2]   METHOD TO DETERMINE DOPAMINE LEVELS AND TURNOVER RATE IN DISCRETE DOPAMINE NERVE-TERMINAL SYSTEMS BY QUANTITATIVE USE OF DOPAMINE FLUORESCENCE OBTAINED BY FALCK-HILLARP METHODOLOGY [J].
AGNATI, LF ;
ANDERSSON, K ;
WIESEL, F ;
FUXE, K .
JOURNAL OF NEUROSCIENCE METHODS, 1979, 1 (04) :365-373
[3]   EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE [J].
ANDEN, NE ;
RUBENSON, A ;
FUXE, K ;
HOKFELT, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) :627-&
[4]   DETERMINATIONS OF CATECHOLAMINE HALF-LIVES AND TURNOVER RATES IN DISCRETE CATECHOLAMINE NERVE-TERMINAL SYSTEMS OF THE HYPOTHALAMUS, THE PREOPTIC REGION AND THE FOREBRAIN BY QUANTITATIVE HISTOFLUORIMETRY [J].
ANDERSSON, K ;
FUXE, K ;
AGNATI, LF .
ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 123 (04) :411-426
[5]  
BANNON M, 1984, NEUROLOGY NEUROBIO B, V8, P25
[6]   ELECTRO-PHYSIOLOGICAL STUDIES ON EMD-23-448, AN INDOLYL-3-BUTYLAMINE, IN THE RAT - A PUTATIVE SELECTIVE DOPAMINE AUTORECEPTOR AGONIST [J].
CHIODO, LA ;
BUNNEY, BS .
NEUROPHARMACOLOGY, 1983, 22 (09) :1087-1093
[7]   EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS [J].
CORRODI, H ;
FUXE, K ;
HOKFELT, T ;
LIDBRINK, P ;
UNGERSTEDT, U .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :409-412
[8]   THE CLASSIFICATION OF DOPAMINE-RECEPTORS - RELATIONSHIP TO RADIOLIGAND BINDING [J].
CREESE, I ;
SIBLEY, DR ;
HAMBLIN, MW ;
LEFF, SE .
ANNUAL REVIEW OF NEUROSCIENCE, 1983, 6 :43-71
[9]  
CREESE I, 1979, MOL PHARMACOL, V16, P69
[10]  
CROW TJ, 1981, BIOL PSYCHIAT, P860